Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesenchymal stem cell modulation is not a single molecule/receptor but rather describes the broad set of mechanisms through which these multipotent stromal/stem cells regulate immunity and promote healing across diverse clinical contexts through paracrine signaling molecules/cytokines/EV release and direct cellular interactions with components of the innate/adaptive immune system.
MSC modulation is achieved through a combination of cytokine secretion, direct cell-cell contact, and extracellular vesicle (EV) release, leading to regulation of immune cell activity and tissue repair processes. Specific examples include IL-6 influencing monocyte/DC differentiation, PGE2 suppressing DC maturation, and TGF-β promoting anti-inflammatory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesenchymal Stem Cell Modulation (MSC Modulation).